uniQure (QURE)

• Market cap: $1.73B
• 1 day: -0.51%
• 5 days: 0.37%
• 1 month: 1.4%
• 3 months: 72.08%
• 6 months: 34.26%
• Year to date: 17.27%
• 1 year: 81.54%
• 5 years: -20.4%
• 10 years: 193.37%
• Sector: Healthcare
• Industry: Biotechnology

About: uniQure NV is a gene therapy company. It develops treatments and platforms for patients suffering from genetic and other devastating diseases. Its products and services are focused on hemophilia, Huntington's disease, and cardiovascular diseases. The company is focused on the development of the pipeline of gene therapies with the collaboration of Bristol Myers Squibb for cardiovascular diseases. Its program and pipeline involves: Huntington's Disease, Temporal Lobe Epilepsy (TLE), Fabry Disease, ALS (SOD1), Hemophilia B, Clinical Trials, and Research Programs.

Employees: 221